Literature DB >> 9861044

Caspase-1 is activated in neural cells and tissue with amyotrophic lateral sclerosis-associated mutations in copper-zinc superoxide dismutase.

P Pasinelli1, D R Borchelt, M K Houseweart, D W Cleveland, R H Brown.   

Abstract

The mechanism by which mutations in the superoxide dismutase (SOD1) gene cause motor neuron degeneration in familial amyotrophic lateral sclerosis (ALS) is unknown. Recent reports that neuronal death in SOD1-familial ALS is apoptotic have not documented activation of cell death genes. We present evidence that the enzyme caspase-1 is activated in neurons expressing mutant SOD1 protein. Proteolytic processing characteristic of caspase-1 activation is seen both in spinal cords of transgenic ALS mice and neurally differentiated neuroblastoma (line N2a) cells with SOD1 mutations. This activation of caspase-1 is enhanced by oxidative challenge (xanthine/xanthine oxidase), which triggers cleavage and secretion of the interleukin 1beta converting enzyme substrate, pro-interleukin 1beta, and induces apoptosis. This N2a culture system should be an instructive in vitro model for further investigation of the proapoptotic properties of mutant SOD1.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9861044      PMCID: PMC28118          DOI: 10.1073/pnas.95.26.15763

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

2.  Superoxide dismutase: improved assays and an assay applicable to acrylamide gels.

Authors:  C Beauchamp; I Fridovich
Journal:  Anal Biochem       Date:  1971-11       Impact factor: 3.365

3.  Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation.

Authors:  M E Gurney; H Pu; A Y Chiu; M C Dal Canto; C Y Polchow; D D Alexander; J Caliendo; A Hentati; Y W Kwon; H X Deng
Journal:  Science       Date:  1994-06-17       Impact factor: 47.728

Review 4.  A radical hypothesis for neurodegeneration.

Authors:  C W Olanow
Journal:  Trends Neurosci       Date:  1993-11       Impact factor: 13.837

5.  ALS, SOD and peroxynitrite.

Authors:  J S Beckman; M Carson; C D Smith; W H Koppenol
Journal:  Nature       Date:  1993-08-12       Impact factor: 49.962

6.  Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis.

Authors:  D R Rosen; T Siddique; D Patterson; D A Figlewicz; P Sapp; A Hentati; D Donaldson; J Goto; J P O'Regan; H X Deng
Journal:  Nature       Date:  1993-03-04       Impact factor: 49.962

7.  Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.

Authors:  J D Rothstein; L A Bristol; B Hosler; R H Brown; R W Kuncl
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Superoxide dismutase activity, oxidative damage, and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis.

Authors:  A C Bowling; J B Schulz; R H Brown; M F Beal
Journal:  J Neurochem       Date:  1993-12       Impact factor: 5.372

9.  Hydrogen peroxide mediates amyloid beta protein toxicity.

Authors:  C Behl; J B Davis; R Lesley; D Schubert
Journal:  Cell       Date:  1994-06-17       Impact factor: 41.582

10.  Programmed cell death and Bcl-2 protection in the absence of a nucleus.

Authors:  M D Jacobson; J F Burne; M C Raff
Journal:  EMBO J       Date:  1994-04-15       Impact factor: 11.598

View more
  47 in total

1.  Recruitment of the mitochondrial-dependent apoptotic pathway in amyotrophic lateral sclerosis.

Authors:  C Guégan; M Vila; G Rosoklija; A P Hays; S Przedborski
Journal:  J Neurosci       Date:  2001-09-01       Impact factor: 6.167

2.  Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis.

Authors:  P Pasinelli; M K Houseweart; R H Brown; D W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 3.  Programmed cell death in amyotrophic lateral sclerosis.

Authors:  Christelle Guégan; Serge Przedborski
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  Mutant dynein (Loa) triggers proprioceptive axon loss that extends survival only in the SOD1 ALS model with highest motor neuron death.

Authors:  Hristelina S Ilieva; Koji Yamanaka; Shelle Malkmus; Osamu Kakinohana; Tony Yaksh; Martin Marsala; Don W Cleveland
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-21       Impact factor: 11.205

Review 5.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

Review 6.  Genetically engineered models relevant to neurodegenerative disorders: their value for understanding disease mechanisms and designing/testing experimental therapeutics.

Authors:  P C Wong; H Cai; D R Borchelt; D L Price
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 7.  Mitochondrial dysfunction in amyotrophic lateral sclerosis.

Authors:  Ping Shi; Jozsef Gal; David M Kwinter; Xiaoyan Liu; Haining Zhu
Journal:  Biochim Biophys Acta       Date:  2009-08-26

8.  Intranasal Delivery of a Caspase-1 Inhibitor in the Treatment of Global Cerebral Ischemia.

Authors:  Ningjun Zhao; Xiaoying Zhuo; Yujiao Lu; Yan Dong; Mohammad Ejaz Ahmed; Donovan Tucker; Erin L Scott; Quanguang Zhang
Journal:  Mol Neurobiol       Date:  2016-08-13       Impact factor: 5.590

9.  Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

Authors:  Jordi Magrané; Isabel Hervias; Matthew S Henning; Maria Damiano; Hibiki Kawamata; Giovanni Manfredi
Journal:  Hum Mol Genet       Date:  2009-09-24       Impact factor: 6.150

10.  Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration.

Authors:  Caroline Rouaux; Natasa Jokic; Corinne Mbebi; Stephanie Boutillier; Jean-Philippe Loeffler; Anne-Laurence Boutillier
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.